Clonazepam: Clinical Trials

7 trials of Clonazepam, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 unknown. 7 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Completed 6, Unknown 1
Phase 11Completed 1
Phase 31Completed 1

Follow Clonazepam: new trials by email Literature Review of Clonazepam trials Research Report on Clonazepam

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Effectiveness of the Selected Method of Treatment of Primary Burning Mouth Syndrome
Clonazepam tablets, tongue pads - Burning Mouth Syndrome, Glossodynia
Phase 2CompletedWroclaw Medical University582019-01-122021-07-22
Effect of Clonazepam on Cannabis Withdrawal and Relapse in Treatment-seeking Patients
Clonazepam, Placebo - Cannabis Use Disorder
Phase 2CompletedNew York State Psychiatric Institute682016-12-012021-08-06
Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson Disease
Melatonin PR, Clonazepam, Melatonin PR placebo - REM Sleep Behavior Disorder, Parkinson Disease
Phase 2UnknownSeoul National University Hospital302016-07-012016-06-03
Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With Parkinsonism
Clonazepam, Placebo - REM Sleep Behavior Disorder
Phase 2CompletedSeoul National University Hospital402015-03-012016-04-25
GABAergic Modulation in Pain Transmission in Human: Effect of the GABAA Agonist Clobazam on Peripheral and Central Sensitisation
Clonazepam, Tolterodine, clobazam - Neuropathic Pain
Phase 1 / Phase 2CompletedUniversity Hospital, Geneva252010-04-012011-12-14
Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures
Clonazepam - Epilepsy
Phase 2CompletedJazz Pharmaceuticals452007-12-012014-07-01
Therapies for Treatment-Resistant Panic Disorder Symptoms
Clonazepam, Sertraline, Cognitive behavioral therapy - Panic Disorder
Phase 2 / Phase 3CompletedMassachusetts General Hospital461999-03-012014-06-11

Conditions studied

Parkinson Disease (2)  ·  REM Sleep Behavior Disorder (2)  ·  Anxiety Disorders (1)  ·  Burning Mouth Syndrome (1)  ·  Epilepsy (1)  ·  Glossalgia (1)  ·  Marijuana Abuse (1)  ·  Neuralgia (1)  ·  Panic Disorder (1)

Sponsors

Seoul National University Hospital (2)  ·  Jazz Pharmaceuticals (1)  ·  Massachusetts General Hospital (1)  ·  New York State Psychiatric Institute (1)  ·  University Hospital, Geneva (1)  ·  Wroclaw Medical University (1)

Countries

United States (3)  ·  South Korea (2)  ·  Finland (1)  ·  Poland (1)  ·  Switzerland (1)

Top investigators

Beom Seok Jeon, MD, Ph.D (1)  ·  Beomseok Jeon, MD, PhD (1)  ·  Beverly Benson, PhD (1)  ·  John Mariani, MD (1)  ·  Naomi M. Simon, MD, MSc (1)

Results publications

PMID 19814948

NIH funding

K23MH001831 (1), U54DA037842 (1)